The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Candesartan 16 mg tablets

16 milligram(s) Tablet

Accord Healthcare Ireland Ltd.PA2315/150/003

Main Information

Trade NameCandesartan 16 mg tablets
Active SubstancesCandesartan cilexetil
Strength16 milligram(s)
Dosage FormTablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/150/003

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA06 candesartan

Status

Authorised/WithdrawnAuthorised
Licence Issued15/04/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available

Generics Information

Interchangeable ListCandesartan 16mg Tablets
Interchangeable List CodeIC0009-038-002
Interchangeable List DocumentPDF of Interchangeable List
« Back